PUBLIC COMPANY
save$BMEABiomea Fusion, Inc.
$BMEASan Carlos, CA, USupdated 2mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
- phase2Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- N/AHuman Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)
- phase1Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants
- phase2Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
- phase1A Phase 1 Study of BMF-500 in Adults With Acute Leukemia
- phase1Food Effect Study in Healthy Volunteers
- phase2Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)
🐶 Hiring Signal
News
- Kura spins diabetes work into a Lilly-backed biotech startupCaspian Therapeutics aims to develop menin inhibitors, which have proven effective against leukemia, for diabetes and other cardiometabolic conditions.biopharma_dive · 24d ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that